13 April 2023
Press Releases
...
-
23 March 2026
-
23 March 2026
Ipsen provides clarifications regarding the succession of Mr. Henri Beaufour – Group governance agreement relating to Beech Tree*
PARIS, FRANCE, 23 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that Beech Tree, which holds directly and indirectly 26.03% of the share capital and 33.05% of the voting rights of Ipsen SA, announces that Altawin, Fondation Alasol and B...
-
29 May 2026
-
29 May 2026
Ipsen announces the launch of an Employee Shareholding Plan
Ipsen announces the launch of an employee shareholding plan...
-
13 May 2026
-
13 May 2026
Ipsen S.A. – Evolution of the composition of the Board of Directors
Ipsen S.A. – Evolution of the composition of the Board of Directors...
-
05 December 2025
-
05 December 2025
Ipsen provides update on legacy of Henri Beaufour
PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be transferred to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour, Ipsen’s Board Member and a representativ...
-
13 May 2026
-
13 May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026...
-
22 April 2026
-
22 April 2026
Ipsen S.A. – Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026 of Ipsen S.A....
-
03 April 2026
-
03 April 2026
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces that Beech Tree — which directly and indirectly holds 26.03% of Ipsen S.A.’s share capital and 33.05% of its voting rights — has obtained from the French Financial Markets A...
-
21 May 2025
-
21 May 2025
Ipsen S.A. – Annual General Meeting held on 21 May 2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025...
-
27 August 2024
-
27 August 2024
Ipsen announces sale of Priority Review Voucher for $158m
PARIS, FRANCE, 27 August 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) has entered into an agreement to sell its rare pediatric disease Priority Review Voucher (PRV) to a large global pharmaceutical company. Ipsen received the PRV coinciding with the SohonosTM ...